Tripep AB (publ) Interim Report for the period January-September 2002
23. Oktober 2002 03:13 ET
|
Tripep
HUDDINGE, Sweden, Oct. 23, 2002 (PRIMEZONE) -- Tripep AB:- A new Board of Directors was elected at the extraordinary shareholders' meeting held on 17 September 2002. The new Board consistsof Rolf L....
Tripep AB (publ): Interim Report for the Period January-June 2002
29. August 2002 08:18 ET
|
Tripep
HUDDINGE, Sweden, Aug. 29, 2002 (PRIMEZONE) -- Tripep AB (publ):
-- Continued work on GPG and its metabolite has made it clear that
the company currently has no candidate drug in the HIV...
Tripep Invests in Drug Against Development and Spread of Multiresistant Bacteria
06. Juni 2002 01:08 ET
|
Tripep
HUDDINGE, Sweden, June 6, 2002 (PRIMEZONE) -- Tripep AB (publ) will subscribe for new shares corresponding to 30% of the share capital in Finnish biotech-company Ipsat Therapies Oy, with an option to...
Tripep AB (publ): Interim Report for the Period January-March 2002 (with link)
26. April 2002 03:49 ET
|
Tripep
HUDDINGE, Sweden, April 26, 2002 (PRIMEZONE) -- Tripep AB (publ):
- A pharmacological pig study designed to determine the best
administration form for GPG(R) will be launched...
Tripep AB (publ) -- Annual General Meeting 2002
09. April 2002 06:45 ET
|
Tripep
HUDDINGE, Sweden, April 9, 2002 (PRIMEZONE) -- At today's Annual General Meeting of Tripep AB (publ), the President reported on the past year and on the development of Tripep's research projects. A...
Tripep AB publ: Year-End 2001 (with links)
25. Januar 2002 04:15 ET
|
Tripep
HUDDINGE, Sweden, Jan. 25, 2002 (PRIMEZONE) -- Tripep AB (publ):
-- New plan adopted, entailing three areas of operation for Tripep:
-- the HIV-inhibiting pharmaceutical GPG(r),
-- a...
Tripep Frees Resources to Pursue Acquisitions
18. Januar 2002 06:18 ET
|
Tripep
STOCKHOLM, Sweden, Jan. 18, 2002 (PRIMEZONE) -- In order to free resources to be used for acquisitions of research companies and in licensing of projects in the clinical phase, Tripep has adopted a...